Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulmonx (LUNG) Accumulated Expenses (2019 - 2025)

Pulmonx has reported Accumulated Expenses over the past 7 years, most recently at $14.6 million for Q4 2025.

  • Quarterly Accumulated Expenses fell 11.63% to $14.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $14.6 million through Dec 2025, down 11.63% year-over-year, with the annual reading at $14.6 million for FY2025, 11.63% down from the prior year.
  • Accumulated Expenses was $14.6 million for Q4 2025 at Pulmonx, down from $14.9 million in the prior quarter.
  • Over five years, Accumulated Expenses peaked at $16.5 million in Q4 2024 and troughed at $9.8 million in Q1 2021.
  • The 5-year median for Accumulated Expenses is $12.6 million (2021), against an average of $12.7 million.
  • Year-over-year, Accumulated Expenses surged 54.5% in 2021 and then fell 13.17% in 2022.
  • A 5-year view of Accumulated Expenses shows it stood at $13.4 million in 2021, then dropped by 0.67% to $13.3 million in 2022, then increased by 22.28% to $16.2 million in 2023, then rose by 1.47% to $16.5 million in 2024, then decreased by 11.63% to $14.6 million in 2025.
  • Per Business Quant, the three most recent readings for LUNG's Accumulated Expenses are $14.6 million (Q4 2025), $14.9 million (Q3 2025), and $14.4 million (Q2 2025).